You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 17, 2025

Actavis Labs Fl Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL, and what generic and branded alternatives to ACTAVIS LABS FL drugs are available?

ACTAVIS LABS FL has eighty-one approved drugs.

There are seven tentative approvals on ACTAVIS LABS FL drugs.

Summary for Actavis Labs Fl

US Patents:	0
Tradenames:	67
Ingredients:	65
NDAs:	81

Drugs and US Patents for Actavis Labs Fl

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Labs Fl Inc	LEVETIRACETAM	levetiracetam	TABLET;ORAL	077408-003	Mar 2, 2009		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Labs Fl Inc	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	079095-001	Mar 24, 2009	AB1	RX	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Labs Fl Inc	TAZTIA XT	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	075401-004	Apr 10, 2003		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Labs Fl Inc	DOXYCYCLINE HYCLATE	doxycycline hyclate	CAPSULE;ORAL	062031-001	Approved Prior to Jan 1, 1982	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Labs Fl Inc	AMPHETAMINE	amphetamine	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	209253-001	Jun 22, 2023		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Labs Fl Inc	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	077715-001	Nov 26, 2008	AB3	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ACTAVIS LABS FL drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.